Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients’

被引:0
|
作者
J Szkandera
M Pichler
M Stotz
A Gerger
机构
[1] Medical University of Graz,Division of Clinical Oncology, Department of Medicine
来源
British Journal of Cancer | 2013年 / 109卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3126 / 3127
页数:1
相关论文
共 50 条
  • [41] Effect of preoperative neutrophil–lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy
    Hsin-Yuan Hung
    Jinn-Shiun Chen
    Chien Yuh Yeh
    Chung-Rong Changchien
    Reiping Tang
    Pao-Shiu Hsieh
    Wen-Sy Tasi
    Jeng-Fu You
    Yau-Tong You
    Chung-Wei Fan
    Jeng-Yi Wang
    Jy-Ming Chiang
    International Journal of Colorectal Disease, 2011, 26 : 1059 - 1065
  • [42] The Derived Neutrophil/Lymphocyte Ratio Predicts Poor Clinical Outcome in Early Stage Non-Small Cell Lung Patients Who Received Stereotactic Body Radiation Therapy
    Luo, H.
    Cui, Y.
    Zheng, X.
    Ge, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E693 - E693
  • [43] Clinical significance of tumor- infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy
    Cha, Yoon Jin
    Park, Eun Jung
    Baik, Seung Hyuk
    Lee, Kang Young
    Kang, Jeonghyun
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [44] Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy
    Yoon Jin Cha
    Eun Jung Park
    Seung Hyuk Baik
    Kang Young Lee
    Jeonghyun Kang
    Scientific Reports, 9
  • [45] Clinical presentation predicts the outcome of patients with colon cancer
    Ben-Ishay, Offir
    Peled, Zvi
    Othman, Amira
    Brauner, Eran
    Kluger, Yoram
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 5 (04): : 104 - 109
  • [46] Association of albumin, neutrophil-lymphocyte ratio and lymphocytes with clinical stage in cervical cancer patients
    Perez-Cruz, Elizabeth
    Howlet-Caballero, Luis Carlos
    Villanueva, Xicotencatl Jimenez
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (02): : 687 - 692
  • [47] COMMENT ON "PROGNOSTIC SIGNIFICANT OF NEUTROPHIL: LYMPHOCYTE RATIO, PLATELET - LYMPHOCYTE RATIO, AND LYMPHOCYTE: MONOCYTE RATIO IN KURDISH PATIENTS WITH BREAST CANCER"
    Pellicciaro, M.
    Berardi, S.
    Materazzo, M.
    Vanni, G.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [48] Clinical score to predict recurrence in patients with stage II and III colon cancer
    Vinal, D.
    Martinez-Recio, S.
    Martinez Perez, D.
    Jimenez-Bou, D.
    Ruiz, I.
    Pena, J.
    Martin-Montalvo, G.
    Alameda, M.
    Rueda-Lara, A.
    Gutierrez-Sainz, L.
    Palacios, M.
    Custodio, A.
    Ghanem, I.
    Feliu, J.
    Rodriguez-Salas, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S279 - S279
  • [49] Molecular profiles and clinical outcome of stage UICC II colon cancer patients
    Jörn Gröne
    Dido Lenze
    Vindi Jurinovic
    Manuela Hummel
    Henrik Seidel
    Gabriele Leder
    Georg Beckmann
    Anette Sommer
    Robert Grützmann
    Christian Pilarsky
    Ulrich Mansmann
    Heinz-Johannes Buhr
    Harald Stein
    Michael Hummel
    International Journal of Colorectal Disease, 2011, 26 : 847 - 858
  • [50] Molecular profiles and clinical outcome of stage UICC II colon cancer patients
    Groene, Joern
    Lenze, Dido
    Jurinovic, Vindi
    Hummel, Manuela
    Seidel, Henrik
    Leder, Gabriele
    Beckmann, Georg
    Sommer, Anette
    Gruetzmann, Robert
    Pilarsky, Christian
    Mansmann, Ulrich
    Buhr, Heinz-Johannes
    Stein, Harald
    Hummel, Michael
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (07) : 847 - 858